Showing results (1841-1850 of 1,960) with videos related to

Sort By:
Pageof 196
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2024
Simplified Risk Stratification Model for Patients With Waldenström MacroglobulinemiaSaurabh Zanwar, Jennifer Le-Rademacher, Eric Durot, et al.
Blood Advances|March 27, 2026
Impact of Novel Therapies on the Efficacy of Post-Transplantation Brentuximab Vedotin Maintenance in Hodgkin LymphomaAyo Samuel Falade, Robert Redd, Sanjal H Desai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphomaMatthew J Maurer, Ivana N M Micallef, James R Cerhan, et al.
Blood|January 17, 2020
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 studyDavid J Straus, Monika Długosz-Danecka, Sergey Alekseev, et al.
Cancer Chemotherapy and Pharmacology|October 28, 2017
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international studyMartin van den Bent, Hui K Gan, Andrew B Lassman, et al.
JCO Oncology Practice|October 14, 2022
High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated CourseDarragh F O'Donoghue, Huong L Truong, Heidi D Finnes, et al.
American Journal of Hematology|August 20, 2018
Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemiaJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
British Journal of Haematology|November 16, 2012
Response assessment in Waldenström macroglobulinaemia: update from the VIth International WorkshopRoger G Owen, Robert A Kyle, Marvin J Stone, et al.
Pageof 196